Synthesis and Quality Control of Calcium Chelidonate Substance with Osteogenic Activity

E. Avdeeva, N. M. Igidov, V. L. Gein, S. Krivoshchekov, I. Khlusov, M. V. Belousov, N. V. Dozmorova, V. Luzhanin
{"title":"Synthesis and Quality Control of Calcium Chelidonate Substance with Osteogenic Activity","authors":"E. Avdeeva, N. M. Igidov, V. L. Gein, S. Krivoshchekov, I. Khlusov, M. V. Belousov, N. V. Dozmorova, V. Luzhanin","doi":"10.33380/2305-2066-2023-12-4(1)-1678","DOIUrl":null,"url":null,"abstract":"Introduction. Osteogenic agents are used for pathologies associated with impaired bone formation, complications of bone fractures, the use of implants and endoprostheses, and tumor lesions of bone tissue. High osteogenic activity in vivo on the model of experimental osteomyelitis, in vitro and in situ on mesenchymal stem cells was revealed for calcium chelidonate, which is a promising substance for the production of osteogenic drugs.Aim. Development of a method for obtaining the calcium chelidonate substance by chemical synthesis and methods of its standardization.Materials and methods. The synthesis of chelidonic acid was carried out on the basis of diethyloxalate; calcium chelidonate – using synthesized chelidonic acid and anhydrous calcium chloride. The structure of the substances was confirmed by optical spectral methods, mass spectrometry, elemental and X-ray structural analysis. The quantitative content was assessed using a liquid chromatograph. Statistical processing of the results of quantitative measurements was carried out in the STATISTICA 8,0 program.Results and discussion. As a result of the synthesis, chelidonic acid (4-oxo-4H-piran-2,6-dicarboxylic acid) was obtained, which is colorless or cream-tinged crystals. The structure of the resulting compound is confirmed by spectral characteristics and elemental analysis data. A method for obtaining the calcium chelidonate substance has been worked out, while the yield of the target product was 100 ± 5 %. By X-ray structural analysis, it was found that the synthesized compound is calcium chelidonate trihydrate [Ca(ChA)(H2O)3]n with M.M. (C7H8O9Ca) 276,15. Methods for establishing authenticity, purity and quantification of the substance have been developed. The amount of impurities in the resulting substance did not exceed 0.1 %, and the content of the main component ranged from 99,2 ± 0,20 to 100,4 ± 0,35 %.Conclusion. Due to the limited resource reserves and the complexity of the process of extracting chelidonic acid from plant raw materials, a method for the chemical synthesis of calcium chelidonate substance with osteogenic activity is proposed. The obtained results provide prospects for further research in the direction of the development and introduction of synthetic calcium chelidonate as a new osteogenic drug, provided that the specific biological activity is comparable to the natural analogue.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"16 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug development & registration","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33380/2305-2066-2023-12-4(1)-1678","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Osteogenic agents are used for pathologies associated with impaired bone formation, complications of bone fractures, the use of implants and endoprostheses, and tumor lesions of bone tissue. High osteogenic activity in vivo on the model of experimental osteomyelitis, in vitro and in situ on mesenchymal stem cells was revealed for calcium chelidonate, which is a promising substance for the production of osteogenic drugs.Aim. Development of a method for obtaining the calcium chelidonate substance by chemical synthesis and methods of its standardization.Materials and methods. The synthesis of chelidonic acid was carried out on the basis of diethyloxalate; calcium chelidonate – using synthesized chelidonic acid and anhydrous calcium chloride. The structure of the substances was confirmed by optical spectral methods, mass spectrometry, elemental and X-ray structural analysis. The quantitative content was assessed using a liquid chromatograph. Statistical processing of the results of quantitative measurements was carried out in the STATISTICA 8,0 program.Results and discussion. As a result of the synthesis, chelidonic acid (4-oxo-4H-piran-2,6-dicarboxylic acid) was obtained, which is colorless or cream-tinged crystals. The structure of the resulting compound is confirmed by spectral characteristics and elemental analysis data. A method for obtaining the calcium chelidonate substance has been worked out, while the yield of the target product was 100 ± 5 %. By X-ray structural analysis, it was found that the synthesized compound is calcium chelidonate trihydrate [Ca(ChA)(H2O)3]n with M.M. (C7H8O9Ca) 276,15. Methods for establishing authenticity, purity and quantification of the substance have been developed. The amount of impurities in the resulting substance did not exceed 0.1 %, and the content of the main component ranged from 99,2 ± 0,20 to 100,4 ± 0,35 %.Conclusion. Due to the limited resource reserves and the complexity of the process of extracting chelidonic acid from plant raw materials, a method for the chemical synthesis of calcium chelidonate substance with osteogenic activity is proposed. The obtained results provide prospects for further research in the direction of the development and introduction of synthetic calcium chelidonate as a new osteogenic drug, provided that the specific biological activity is comparable to the natural analogue.
具有成骨活性的螯合钙物质的合成与质量控制
导言。成骨剂用于治疗与骨形成障碍有关的病症、骨折并发症、植入物和内假体的使用以及骨组织的肿瘤病变。在实验性骨髓炎模型、体外和原位间充质干细胞中发现,螯合钙具有很高的成骨活性,是一种很有希望生产成骨药物的物质。开发通过化学合成获得螯合酮酸钙物质的方法及其标准化方法。在二乙基己二酸的基础上合成了螯合酮酸;螯合酮酸钙--使用合成的螯合酮酸和无水氯化钙。这些物质的结构是通过光学光谱法、质谱法、元素分析和 X 射线结构分析确认的。使用液相色谱仪对定量含量进行了评估。定量测量结果的统计处理在 STATISTICA 8.0 程序中进行。合成结果得到了蝶啶酸(4-氧代-4H-吡喃-2,6-二羧酸),它是无色或乳白色晶体。光谱特征和元素分析数据证实了所得化合物的结构。已研究出一种获得螯合钙物质的方法,目标产物的收率为 100 ± 5%。通过 X 射线结构分析,发现合成的化合物为三水螯合钙[Ca(ChA)(H2O)3]n,熔点为(C7H8O9Ca)276,15。已开发出确定该物质真实性、纯度和定量的方法。所得物质中的杂质含量不超过 0.1%,主要成分的含量在 99.2 ± 0.20% 到 100.4 ± 0.35% 之间。由于资源储量有限以及从植物原料中提取螯合酮酸过程的复杂性,提出了一种化学合成具有成骨活性的螯合酮酸钙物质的方法。所获得的结果为进一步研究合成螯合酮酸钙作为一种新的成骨药物的开发和引进提供了前景,前提是其特定生物活性与天然类似物相当。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信